In hereditary hemorrhagic telangiectasia (HHT), mutations in ENG or ACVRL1 are frequently observed, while SMAD4 mutations affect a small percentage of patients. This evidence concerns the gene SMAD4 and hereditary hemorrhagic telangiectasia.